Navigation Links
StressVue Exercise Stress Testing System

ProductsStressVue Exercise Stress Testing System
Company Philips Medical Systems
Item StressVue Exercise Stress Testing System
Features 
  • Simultaneous ECG input from 12 leads
  • Zoomed EC
  • Averages
  • Running Trends
  • METS
  • Total Exercise Time
  • Treadmill control
  • HR and Target %
  • ST Level
  • NIBP Value
  • Description StressVue puts leading-edge stress testing within reach of virtually any facility...from a physician's office or clinic to the most advanced cardiology hospital. This PC-based system includes a vivid flat panel monitor with options for a Philips ergonomic stress cart and a thermal printer for continuous printing. StressVue is designed to interface with the TrackMaster Treadmill, Ergoline and Lode Ergometers, and the Suntech Tango Motion-Tolerant Blood Pressure Monitor to create a comprehensive stress testing system.
    Info Philips Medical SystemsCall Philips Medical Systems to buy products (US and Canada only; other locations use number below) USACanada1-866-745-0519

    Customer Service: 1-800-722-7900
    Web site: http://www.medical.philips.com/

    Related medicine products :

    1. ExTOL Exercise Stress Systems
    2. Quest Exercise Stress System
    3. CASE 8000 Cardiac Assessment System for Exercise
    4. X-Scribe II Stress Exercise System
    5. PCE-110 PC-Based Exercise Stress System
    6. PCE-210 PC-Based Exercise Stress System
    7. Tango Exercise Stress BP Monitor
    8. Burdick HeartStride Exercise Stress System
    9. Physiological Stress Loaded (P.S.L.) Stem
    10. Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones
    11. BioStress 2000
    ...d human blood cells provides a simple, cost effect...ation of urine prior to microscopic analysis in co...tion of urine sediment is a moderately complex tes...and quantitative values are provided for standardi...
    ...enience for urinalysis quality control one bottle...product for dipstick, hCG, and microscopics qualit...nine and microalbumin. Values are provided for mic... qualitative results for hCG are also included. Di...
    ... is ideal for most life science applications, espe...tented* PathCheck sensor technology senses the dep...alizes the absorbance value to a 1-cm pathlength. ... obtained in a conventional spectrophotometer. ,...
    The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best
    Medicine Products:
    (Date:5/16/2008)...e Vital Services for Frail Seniors and People With...e-USNewswire/ -- Thousands of,homecare workers acr...negger,s proposed cuts to hours of service, wages ...,s most vulnerable workers and the,people they ser... vital,services for seniors and people with disabi...
    (Date:5/16/2008)... Urban Health Institute with 10,000 Sensual O Cond... Playboy Mansion Fundraiser, LOS ANGELES, May 16 ...p,and R & B artist J Kwon known best for his hit s... presenting the Urban Health Institute (UHI) with,... $50,000. The donation is,being made to promote th...
    (Date:5/16/2008)...determine who would benefit most from chemo after ...HealthDay News) -- A panel of 15 genes may help de...cell lung cancer will experience a recurrence and,...new study shows. , By extension, the same gene... aggressive forms of the cancer who would be able ...
    (Date:5/16/2008)...May 16 /PRNewswire-USNewswire/ -- As tropical stor...awaddy delta, survivors of,Cyclone Nargis are vuln...,survivors still need assistance, as exposure to t...ncreasingly dire situation., "The people living i...ver from this disaster and get back on their feet,...
    Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2
    ...ealth (OIE) said that the risk of the H5N1 strain ...general Bernard Vallat reported this to the French...he United States and Canada in the same risk categ...ikely to be transmitted from Indonesia by migrator...
    ...have identified the deadly H5N1 virus in geese, du...thern China, sparking fears of bird flu pandemic//...ural hosts of the bird flu virus. This however is ...omatic bird flu infection has been detected among ...
    ...t Ralph Klein's plan to reform the provincial heal...d that the third way debate// is like a dead end w...had ever imagined. Archbishop Tom Collins is disap...is highly dependent upon the patient’s financial c...
    ...nd investigate complaints. The Institute of Medici...(QIO) which is responsible for attending to patien... be given to various other organizations. This is ... issued fewer provider sanctions in recent years. ...
    Other Medicine News:Health News:Healthy, Bird Flu Infected Chickens In Chinese Markets 2
    (Date:5/15/2008)...monstrated in Blacks, Hispanics/Latinos, People ..., PARSIPPANY, N.J., May 15 /- Daiich...d at the American Society of,Hypertension,s Twenty...w,Orleans demonstrated that the powerful combinati...mil) safely and effectively helped,patients across...
    (Date:5/15/2008)...d with a newly cleared device to identify the, li... are associated with complicatio...5 /- InfraReDx, Inc. today,announced ... Mich., have,successfully used its LipiScan(TM) Co...rdiac catheterization. This is the first patient i...
    (Date:5/15/2008)...May 15 /- Ergonex Pharma today,announ...ation (FDA) has,granted orphan drug designation to... hypertension (PAH). Terguride is currently being ...urope., "The FDA,s grant of orphan drug designati... our development program by offering regulatory,c...
    (Date:5/15/2008)...y 15 /- Tigris Pharmaceuticals,Inc. ...earch and,Development Agreement (CRADA) with the N...linical and preclinical development of AFP-464, an...P-464 is converted to,metabolites which bind coval...tosis., This is part of a four-year CRADA encompa...
    Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3The Quigley Corporation Reports First Quarter 2008 Results Increases Investment in Pharmaceutical R 26D Future 17613 1The Quigley Corporation Reports First Quarter 2008 Results Increases Investment in Pharmaceutical R 26D Future 17613 2The Quigley Corporation Reports First Quarter 2008 Results Increases Investment in Pharmaceutical R 26D Future 17613 3The Quigley Corporation Reports First Quarter 2008 Results Increases Investment in Pharmaceutical R 26D Future 17613 4The Quigley Corporation Reports First Quarter 2008 Results Increases Investment in Pharmaceutical R 26D Future 17613 5Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 1Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 2Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 3Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 4Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 5Pharmacyclics Reports Third Quarter 2008 Financial Results 17611 6Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 1Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 2Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 3Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 4Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 5Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 6Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 7Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 8Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 9Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 10Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 11Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 12Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 13Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 1Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 2Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 3Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 4Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 5Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 6Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 7Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 8Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 9Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 10Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 11Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 12Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 13Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 14Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 15Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 16Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 17Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 18Strong Double Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol Myers Squibb Company 4829 19
    ...-- Berlex, Inc., a U.S.,affiliate of Bayer Scherin...of a retrospective study demonstrating that the pr...develop in response to,Betaseron(R) (interferon be...n patients with multiple sclerosis (MS).(1) The st... three continents. It,is the largest dataset ever ...
    ... 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX...of Proellex(TM), an oral drug being developed to,r...ggests that,treatment with Proellex results in a s...ptoms associated with uterine,fibroids and is gene... This 12 week, double-blind study compared two dos...
    Other Medicine Technology:Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 2Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 3Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5